Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5.

Slides:



Advertisements
Similar presentations
Medical Retina and Macular Diseases
Advertisements

Diabetes and the Eye Presented to DES chapters by the Canadian Association of Optometrists.
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
Evan (Jake) Waxman MD PhD
DIABETIC RETINOPATHY Diabetic retinopathy is a frequent cause of blindness. The exact cause of diabetic microvascular disease is unknown.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
SHAWN RICHARDS, MD MOSES LAKE CLINIC MOSES LAKE, WA Common Retinal Diseases.
Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.
Prevalence of Diabetic Retinopathy In Diabetic patients cared for at the Family Care Center at RCRMC Kam Chan, DO [ role of BP & glycemic control ]
DIABETIC RETINOPATHY.
M.R.AKHLAGHI MD  It is based on ophthalmoscopic signs.
Nonsurgical management of diabetic retinopathy Ghanbari MD 1388:11:30.
Ines Serrano MD Evan Waxman MD PhD
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
به نام خداوند جان و خرد. دکتر نادر طاهری متخصص داخلی فوق تخصص غدد Refrence:ADA(2012) and William textbook of endocrinology.
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Diabetic Retinopathy. Diabetic retinopathy is the most common cause of new cases of blindness among adults years of age. Each year, between 12,000.
Topic assignment : medical ophthalmology
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
Diabetic Retinopathy (DR) Ayesha S Abdullah
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Diabetic Retinopathy.
Hypertensive Retinopathy
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 2.
Diagnosis & Management of Diabetic Eye Disease Part 1 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
Diagnosis & Management of Diabetic Eye Disease Part 7 A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 4 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
OPHTHALMOLOGY DIABETES
Diabetic Retinopathy (DR) Ayesha S Abdullah
UKHDS (UKPDS): UK Hypertension in Diabetes Study Purpose To determine whether tight control of blood pressure (aiming for BP
Impatto della terapia ipoglicemizzante sulla retinopatia diabetica Raffaele Napoli Dipartimento di Scienze Mediche Traslazionali Università Federico II.
Josephine Carlos-Raboca, M.D. Makati Medical Center
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 1 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Diabetic Retinopathy Alan D. Letson, MD Professor & William H. Havener Chair in Ophthalmology Department of Ophthalmology Part I:
 Diabetic retinopathy is defined as a chronic, progressive, potentially sight-threatening disease of the retinal microvasculature. 1  Long-term hyperglycaemia.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 2 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Philip Anderton BOptom PhD Visiting Optometrist Manilla Health Service HNEAHS.
RETINA Dr. G. Rajasekhar D.N.B, FRCS (Glasgow). RETINA  ARTERY OCCLUSIONS  VEIN OCCLUSIONS  DIABETIC RETINOPATHY  CENTRAL SEROUS RETINOPATHY  HYPERTENSIVE.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 4.
Mindy J Dickinson, OD Midwest Eye Care, PC NPDR PDR CSME A1c NVE FBS IDDM NIDDM NVD IRMA CWS FA OCT.
Diabetes and the eye Dr. rania ghosen Diabetic eye disease comprises a group of eye conditions that affect people with diabetes. These conditions include:
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
How Diabetes Steals Vision from Your Patients
I NTEGRATED CARE B ASED ON THE G UIDELINES FOR PATIENTS WITH DIABETIC RETINOPATHY By Yanira I. Marrero McFaline MD.
Diabetic Retinopathy References Introduction of Process
Glossophobia.
Dr.Ravi kant Associate Professor Medicine ,AIIMS Rishikesh
Classification and treatment of Diabetic Retinopathy
Diabetic Retinopathy Screening: A Public Health Perspective
Department of Ophthalmology AIIMS, Rishikesh
Ocular Manifestations of Diabetes
DIABETIC RETINOPATHY Süleyman ÖZEN.
F.Fazel,MD. F.Fazel,MD The treatment of Diabetic Retinopathy.
Macrovascular Complications Microvascular Complications
366 میلیون نفر در جهان مبتلا به دیابت هستند.
The Diabetic Retinopathy Clinical Research Network
Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes
Diabetic retinopathy: Breaking the barrier
January 16, 2019.
Diabetic Retinopathy Clinical Research Network
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
FLAME Lecture: 13 Marshburn
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Fluorescein Angiography (FA) Used to monitor progression and leakage of vessels in retinopathy Inject yellow dye into vein in hand/arm and take.
A: Probability of retinopathy-free survival.
Presentation transcript:

Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5

Diabetic Retinopathy Chronic hyperglycemia unleashes a progressive cascade of events Chronic hyperglycemia unleashes a progressive cascade of events Endothelial pericyte loss Endothelial pericyte loss RGC death RGC death Increased vascular permeability Increased vascular permeability Capillary closure Capillary closure Release of vasoproliferative factors Release of vasoproliferative factors Neovascularization, fibrovascular vitreo-retinal adhesions, vitreous hemorrhage Neovascularization, fibrovascular vitreo-retinal adhesions, vitreous hemorrhage

Diabetic Retinopathy Hypertension and increased retinal blood flow accelerate DR Hypertension and increased retinal blood flow accelerate DR Dyslipidemia aggravates diabetic macular edema Dyslipidemia aggravates diabetic macular edema Most (60%) of patients have some DR after ten years Most (60%) of patients have some DR after ten years Electrophysiologic abnormalities are present within the first year (mfERG) Electrophysiologic abnormalities are present within the first year (mfERG)

Retinopathy - Management Improve blood glucose, blood pressure & blood lipids Improve blood glucose, blood pressure & blood lipids HbA1c < 6.5% HbA1c < 6.5% BP < 130/80 (ideally, < 120/75) BP < 130/80 (ideally, < 120/75) LDL-C < 100 & TGs < 150 LDL-C < 100 & TGs < 150 Limit glycemic variability Limit glycemic variability Mean Blood Gluose > 2 X Standard Deviation Mean Blood Gluose > 2 X Standard Deviation Photocoagulation for PDR, CSME or severe NPDR in T2DM Photocoagulation for PDR, CSME or severe NPDR in T2DM

In the DCCT, “Intensive” Blood Glucose Control (less glycemic fluctuation) Decreased the Risk of Developing DR by 60% compared with “Conventional” Control (more fluctuation) For Patients Having IDENTICAL HbA1c

Staging of Diabetic Retinopathy New proposed international standard New proposed international standard No Apparent DR no retinal findings Mild NPDR microaneurysms only Moderate NPDR > ‘mild’ but < ‘severe’ Severe NPDR > 20 hemorrhages in 4 quads or definite vein beading in 2+ quads or IRMA in 1+ quads (4-2-1 rule) PDR definite NVD or NVE and/or VH/PRH Ophthalmology, 2003 Sept: 110(9):

DR - Pearls For HbA1c values between 5% and 8%, each 10% reduction (e.g. from 8% to 7.2%) lowers the risk of DR progression by 43% For HbA1c values between 5% and 8%, each 10% reduction (e.g. from 8% to 7.2%) lowers the risk of DR progression by 43% In the UKPDS, a 10/5 mm drop in BP cut the risk of severe vision loss in half In the UKPDS, a 10/5 mm drop in BP cut the risk of severe vision loss in half Patients with two or more findings of Severe NPDR have a 45% chance of PDR within 1 year Patients with two or more findings of Severe NPDR have a 45% chance of PDR within 1 year ‘High Risk’ PDR if NVD > ½ DD, or NVD/NVE with VH/PRH ‘High Risk’ PDR if NVD > ½ DD, or NVD/NVE with VH/PRH Untreated, 50% of patients with PDR are blind within 5 years Untreated, 50% of patients with PDR are blind within 5 years